| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |